image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Energean

January 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • ENOG
  • Price:
  • 993p
I highlighted Energean again last time at the maximum point of uncertainty and the shares duly spiked as the group said it had been unaffected by the Gaza crisis. Thanks to the ramp up in production at its flagship Karish field, which started up in Q4 ‘22, group production has risen to above 150,000 barrels oil equivalent, driving revenues of US$1bn and adjusted EBITDAX of US$623m in the nine months ended September with a cost of US$11.2 / barrel better than the US$12 forecast. A dividend of 30 cents was declared for Q3 ‘23 but that’s just a taster. With annual revenues and EBITDA set to rise to US$2.5bn and US$1.75bn, respectively once production hits 200,000 boepd early in 2025, analysts think annual dividends could rise ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X